Currently, biopharmaceutical companies are concentrating on improving treatment regimens, more effective therapies and preventive vaccines that are either in clinical trials or awaiting review by the Food and Drug Administration (FDA) are in progress
• A first-in-class medicine intended to prevent HIV from breaking through the cell membrane.
• A cell therapy that modifies a patient’s own cells in an attempt to make them resistant to HIV.
• A therapeutic vaccine designed to induce responses from T cells that play a role in immune protection against viral infections
